News

Kaiser Permanente is initiating a clinical trial to help obese women control their weight during pregnancy. The ‘Healthy Moms’ study, funded by a $2.2m grant from the National

Molecular Insight Pharmaceuticals (Molecular Insight) has executed an exclusive 10-year agreement to supply the Onalta 90-Y edotreotide radiotherapeutic to BioMedica Life Sciences. Onalta is a novel radiotherapeutic product

Lonza and Alnara Pharmaceuticals (Alnara) have signed an agreement to manufacture Alnara’s lead product liprotamase. Liprotamase is a novel, oral, pancreatic enzyme replacement therapy (PERT) for patients with

MeadWestvaco (MWV) and Persistent Systems have announced that MWV has sold its Paxonix business to software development services company, Persistent Systems. Paxonix provides web-based branding and packaging process

VeriChip has entered into a strategic partnership with the Diabetes Research Institute (DRI) to combine efforts on the further development of the glucose-sensing radio frequency identification (RFID) microchip,

MacuSight has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company’s proprietary ocular sirolimus product, for the treatment of diabetic

Wellstat Therapeutics (Wellstat) and Sanofi-Aventis have entered into a global licensing agreement to develop, manufacture and commercialise PN2034, a first-in-class oral insulin sensitizer for the treatment of Type

Peregrine Pharmaceuticals has reported positive results from its phase II trial evaluating bavituximab in combination with docetaxel, in patients with advanced breast cancer. Bavituximab is a monoclonal antibody

The Scottish Medicines Consortium (SMC) has approved Tibotec’s once daily Prezista (darunavir) for use within NHS Scotland. Darunavir is a protease inhibitor (PI) indicated for the treatment of